This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

15 Mar 2011

PROLOR Biotech Relocates R&D Facility

PROLOR Biotech took a major step towards prominence with the announcement of relocation and expansion of their corporate offices and their R&D facility.

PROLOR Biotech, Inc., a clinical stage biopharmaceutical company, is relocating its corporate office and R&D facility to a larger building located near its current site in the Weizmann Science Park in Israel.

The new headquarters and upgraded R&D facility comprise approximately 10,000 sq. ft. of leased space, allowing for growth in all areas, including new drug research and clinical development. The expanded R&D facility includes clean rooms for GMP-grade production of therapeutic drug candidates for the production of a variety of therapeutic proteins for R&D applications.

"We are excited that this move gives us the opportunity to upgrade our R&D facility, allowing for the planned expansion in R&D headcount and activity needed to accomplish the ambitious goals we

Related News